Compare MEI & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEI | ABEO |
|---|---|---|
| Founded | 1946 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.3M | 281.0M |
| IPO Year | N/A | 1980 |
| Metric | MEI | ABEO |
|---|---|---|
| Price | $6.90 | $5.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $11.50 | ★ $18.20 |
| AVG Volume (30 Days) | 329.8K | ★ 1.3M |
| Earning Date | 12-03-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.29 |
| Revenue | ★ $984,400,000.00 | $400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.51 | $1,589.77 |
| P/E Ratio | ★ N/A | $4.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.08 | $3.93 |
| 52 Week High | $13.31 | $7.54 |
| Indicator | MEI | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 58.38 |
| Support Level | $6.77 | $4.80 |
| Resistance Level | $7.04 | $5.55 |
| Average True Range (ATR) | 0.28 | 0.26 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 24.11 | 75.93 |
Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.